Showing results (121-130 of 2,613) with videos related to
Sort By:
Pageof 262
The American Journal of Pathology|December 14, 2011
The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complicationsBéla Horváth, Partha Mukhopadhyay, György Haskó, et al.Cell Calcium|December 15, 2000
Control of apoptosis by IP(3) and ryanodine receptor driven calcium signalsG Hajnóczky, G Csordás, M Madesh, et al.The Journal of Physiology|December 19, 2000
Quantification of calcium signal transmission from sarco-endoplasmic reticulum to the mitochondriaP Pacher, P Csordás, T Schneider, et al.The American Journal of Pathology|April 20, 2025
An Update on IL-22 Therapies in Alcohol-Associated Liver Disease and BeyondLihong Fu, Burhan Yokus, Bin Gao, et al.International Journal of Molecular Medicine|June 1, 2013
Role of poly(ADP-ribosyl)ation in a 'two-hit' model of hypoxia and oxidative stress in human A549 epithelial cells in vitroKatalin Erdélyi, Pál Pacher, László Virág, et al.ACS Chemical Neuroscience|July 18, 2024
Targeting Oxidative Stress in Neurodegenerative Disorders: A Novel Role for PCSK9 Inhibition?Lauren M Park, Pal Pacher, Falk W LohoffACS Chemical Neuroscience|July 9, 2026
PCSK9 as an Emerging Target for Cerebrovascular Dysfunction and Neuroinflammation in Ischemic StrokeCarolina Vela, Josephin Wagner, Pal Pacher, et al.Phytochemistry|August 29, 2001
Stress induced carbazole phytoalexins in Glycosmis speciesT Pacher, M Bacher, O Hofer, et al.Stroke|September 2, 1999
Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel openerZ Ungvari, P Pacher, V Kecskeméti, et al.Expert Opinion on Investigational Drugs|April 5, 2011
Investigational A₃ adenosine receptor targeting agentsBalázs Koscsó, Balázs Csóka, Pál Pacher, et al.Pageof 262